Association of Pharmacogenetic Markers With Atazanavir Exposure in HIV‐Infected Women-Reference-Cited by-同舟云学术

Association of Pharmacogenetic Markers With Atazanavir Exposure in HIV‐Infected Women

Published:2019-09-28 Issue:2 Volume:107 Page:315-318
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Tamraz Bani¹,Huang Yong¹,French Audrey L.²,Kassaye Seble³,Anastos Kathryn⁴,Nowicki Marek J.⁵,Gange Stephen⁶,Gustafson Deborah R.⁷,Bacchetti Peter⁸,Greenblatt Ruth M.¹⁸,Hysi Pirro G.⁹¹⁰,Aouizerat Bradley E.¹¹,

Affiliation:

1. School of Pharmacy University of California San Francisco San Francisco California USA

2. Infectious Diseases CORE Center/Stroger Hospital of Cook County Chicago Illinois USA

3. Department of Medicine Georgetown University Washington DC USA

4. Departments of Medicine and Epidemiology and Population Health Albert Einstein College of Medicine Bronx New York USA

5. Department of Medicine University of Southern California Los Angeles California USA

6. John Hopkins Bloomberg School of Public Health Baltimore Maryland USA

7. Department of Neurology State University of New York – Downstate Medical Center Brooklyn New York USA

8. Department of Epidemiology and Biostatistics School of Medicine University of California San FranciscoCalifornia USA

9. Department of Twin Research and Genetic Epidemiology King's College London London UK

10. Great Ormand Street Institute for Child Health University College London London UK

11. Bluestone Center for Clinical Research College of Dentistry New York University New York New York USA

Funder

University of California, San Francisco

National Institute of Allergy and Infectious Diseases

National Institute of Child Health and Human Development

Clinical and Translational Science Institute, University of California, San Francisco

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.1605

Reference10 articles.

1. A Genome-Wide Association Study Identifies a Candidate Gene Associated With Atazanavir Exposure Measured in Hair

2. Successful pharmacogenetics-based optimization of unboosted atazanavir plasma exposure in HIV-positive patients: a randomized, controlled, pilot study (the REYAGEN study)

3. Intracellular accumulation of atazanavir/ritonavir according to plasma concentrations and OATP1B1, ABCB1 and PXR genetic polymorphisms

4. Genetic factors influencing atazanavir plasma concentrations and the risk of severe hyperbilirubinemia

5. Association of a Single‐Nucleotide Polymorphism in the Pregnane X Receptor (PXR63396C→T) with Reduced Concentrations of Unboosted Atazanavir

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Finding New Drugs for Infectious Diseases: Development Times and Success Rates;Clinical Pharmacology & Therapeutics;2020-01-21

2. Factors influencing hair lamivudine concentration among people living with HIV in Guangxi, China;Antiviral Therapy;2020

3. ASIC1a induces synovial inflammation via the Ca2+/NFATc3/ RANTES pathway;Theranostics;2020